BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 34532773)

  • 21. PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy.
    Li XY; Chen MJ; Liang XN; Yao RX; Shen B; Wu B; Li G; Sun YM; Wu JJ; Liu FT; Yang YJ; Wang J;
    J Parkinsons Dis; 2023; 13(1):83-91. PubMed ID: 36591660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher prevalence of idiopathic normal pressure hydrocephalus-like MRI features in progressive supranuclear palsy: An imaging reminder of atypical parkinsonism.
    Fu MH; Huang CC; Wu KLH; Chen YF; Kung YC; Lee CC; Liu JS; Lan MY; Chang YY
    Brain Behav; 2023 Feb; 13(2):e2884. PubMed ID: 36635882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
    Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and diagnostic potential of R
    Beliveau V; Müller C; Steiger R; Gizewski ER; Poewe W; Seppi K; Scherfler C
    Parkinsonism Relat Disord; 2022 Aug; 101():43-48. PubMed ID: 35792337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy.
    Quattrone A; Crasà M; Morelli M; Vescio B; Augimeri A; Gramigna V; Quattrone A
    Parkinsonism Relat Disord; 2022 Jun; 99():84-90. PubMed ID: 35642995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome.
    Satoh R; Weigand SD; Pham NTT; Ali F; Arani A; Senjem ML; Jack CR; Whitwell JL; Josephs KA
    Mov Disord; 2023 Dec; 38(12):2282-2290. PubMed ID: 37772771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.
    Quattrone A; Morelli M; Quattrone A; Vescio B; Nigro S; Arabia G; Nisticò R; Novellino F; Salsone M; Arcuri P; Luca A; Mazzuca A; Alessio C; Rocca F; Caracciolo M
    Parkinsonism Relat Disord; 2020 Mar; 72():1-6. PubMed ID: 32036297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.
    Rana AQ; Qureshi AR; Siddiqui O; Sarfraz Z; Rana R; Shtilbans A
    J Neurol; 2019 Sep; 266(9):2093-2102. PubMed ID: 30238268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive supra-nuclear palsy: frequency of cardinal extrapyramidal features at first presentation.
    Pradhan S; Tandon R
    Postgrad Med J; 2015 May; 91(1075):274-7. PubMed ID: 25964368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.
    Wittstock M; Pohley I; Walter U; Grossmann A; Benecke R; Wolters A
    J Neural Transm (Vienna); 2013 Mar; 120(3):453-61. PubMed ID: 22892823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suicidal and death ideation in patients with progressive supranuclear palsy and corticobasal syndrome.
    Ou R; Wei Q; Hou Y; Zhang L; Liu K; Xu X; Gu X; Lin J; Jiang Z; Liu J; Song W; Cao B; Shang H
    J Affect Disord; 2020 Nov; 276():1061-1068. PubMed ID: 32768878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
    Linder J; Stenlund H; Forsgren L
    Mov Disord; 2010 Feb; 25(3):341-8. PubMed ID: 20108376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism.
    Yoon WT
    Neurol Neurochir Pol; 2018; 52(1):48-53. PubMed ID: 29196058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study.
    Jecmenica-Lukic M; Petrovic IN; Pekmezovic T; Kostic VS
    J Neurol; 2014 Aug; 261(8):1575-83. PubMed ID: 24888315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.